1.Accuracy of Dose Estimation in High Dose Rate Intracavitary Radiotherapy of Carcinoma of the Uterine Cervix.
Seung Jae HUH ; Sung Whan HA ; Kyu Young CHOI
Journal of the Korean Society for Therapeutic Radiology 1987;5(2):137-140
In brachytherapy of uterine cervical cancer using a high dose rate remote afterloading system, it is of prime importance to deliver a accurate dose in each fractionated treatment by minimizing the difference between the pre-treatment planned and post-treatment calculated doses. The post-treatment calculated point A dose was not much different from the pretreatment planned dose (500 cGy). The average+/-standard deviation was 500+/-18 cGy and 84 percent of 82 intracavitary radiotherapy was within the range of 500+/-25 cGy.
Brachytherapy
;
Cervix Uteri*
;
Female
;
Radiotherapy*
;
Uterine Cervical Neoplasms
2.Radiotherapeutic management in carcinoma of the uterine cervix: GOG experience.
Yonsei Medical Journal 1992;33(2):97-103
No abstract available.
Cervix Neoplasms/*radiotherapy
;
Female
;
Human
;
Neoplasm Metastasis
;
Pregnancy
3.Fractionated High-Dose-Rate Brachytherapy in the Management of Uterine Cervical Cancer.
Hee Chul PARK ; Chang Ok SUH ; Gwi Eon KIM
Yonsei Medical Journal 2002;43(6):737-748
It is well known that intracavitary radiotherapy (ICR), either alone or in combination with external-beam radiotherapy (EBRT) is an essential component of the radiation treatment of uterine cervical cancer. Although low-dose-rate (LDR) brachytherapy has been successfully applied to the management of such patients, several radiation oncologists have experience of using high-dose-rate (HDR) brachytherapy with promising clinical results over the past 4 decades. However, there has been a considerable reluctance by radiation oncologists and gynecologists in North America to employ the HDR remote afterloading technique instead of the more firmly established LDR treatment modality. In contrast, the HDR-ICR system is rapidly gaining acceptance in Korea since the introduction of the Ralstron, remotely controlled afterloading system using HDR Co-60 sources, at the Yonsei Cancer Center in 1979. According to brachytherapy statistics reported by the Korean Society of Therapeutic Radiology and Oncology, in 1997, brachytherapy was performed upon 1,758 Korean patients with uterine cervical cancer, of whom approximately 83% received HDR brachytherapy. In this review, we present our experiences of HDR-ICR for the treatment of uterine cervical cancer. In addition, we discuss the controversial points, which are raised by those considering the use of HDR-ICR for uterine cervical cancer; these issues include physical and radiobiological considerations, and the prospect of future technical improvements.
Brachytherapy/*methods
;
Cervix Neoplasms/*radiotherapy
;
Dose Fractionation
;
Female
;
Human
;
Radiotherapy Planning, Computer-Assisted
4.Use of the Rectal Retractor to Reduce the Rectal Dose in High Dose Rate Intracavitary Brachytherapy for a Carcinoma of the Uterine Cervix.
Kyu Chan LEE ; Tae Hyun KIM ; Jin Ho CHOI ; Myung Sun CHOI ; Chul Yong KIM ; Joo Young KIM
Yonsei Medical Journal 2004;45(1):113-122
Commercially available rectal retractors can be used in high dose rate intracavitary brachytherapy (HDR ICR) as one of the methods for reducing the rectal dose in radiotherapy for a uterine cervical cancer. However, the extent of the rectal protection achieved using these rectal retractors has not been reported. The aim of the study was to examine the effect of a rectal retractor on reducing the rectal dose in HDR ICR. Thirty patients were treated with HDR ICR using rectal retractors. Tandem and ovoids were applied in 15 patients and ovoids only were used in the other 15 patients. During the simulation, the rectum was filled with barium, and anteroposterior and lateral radiographs were then taken with and without the rectal retractor. Along the anterior rectal wall outlined, 4 to 8 points (median 6) were chosen to calculate the dose for each patient including the rectal point (RP), which is an author-defined rectal point modified from the definition of the rectal reference point in the ICRU report 38. The length of the measured rectum was 3-7 cm (median 5 cm). The bladder point (BP) dose was measured as recommended by the ICRU. The prescription doses to point A varied from 3.5 to 5 Gy (median 4 Gy). Paired comparisons were made on the individual patients by calculating the normalized mean doses of the RP, the maximal point (MP), and the longitudinal average (LA) with and without the rectal retractor. The doses to the bladder points (BP) were also calculated in parallel to the rectal points. The anterior rectal walls were displaced posteriorly after inserting the rectal retractor. In the tandem and ovoids group, the number of patients with a reduced dose in the RP, MP and LA were 14 (93.3%), 12 (80.0%) and 13 (86.7%), respectively. In the ovoids only group, the corresponding figures were 14 (93.3%), 14 (93.3%) and 14 (93.3%). In the tandem and ovoids group, the reduced dose in the RP, MP, and LA dose were 0.52 Gy (13.0%), 0.50 Gy (12.5%), and 0.39 Gy (9.8%), respectively (p < 0.05). In the ovoids only group, the RP, MP, and LA dose were reduced by 0.62 Gy (15.5%), 0.92 Gy (23.0%), and 0.54 Gy (13.5%), respectively (p < 0.05). There was no significant change in the bladder point doses when the rectal retractor was applied, although the mean BP dose were 0.27 Gy and 0.09 Gy lower for the tandem and ovoids group and for ovoids only group, respectively (p > 0.05). The mean RP, MP, and LA dose reduction rates of the patient subgroup where the RP dose was < 70% of the prescription dose were compared with the subgroup where the RP dose was > 70%. The effect of the rectal dose reduction was significant only in the subgroup of patients who received > 70% of the prescription dose (p < 0.05). The use of the rectal retractor was a simple and an effective method for reducing the rectal dose. It was also considered to be a highly reproducible method, which can replace the time-consuming vaginal gauze packing in HDR-ICR.
Brachytherapy/*instrumentation/methods
;
Cervix Neoplasms/*radiotherapy
;
Female
;
Human
;
Radiotherapy Dosage
;
*Rectum
;
Surgical Instruments
;
Vagina
5.A case of recurrent cervix cancer with lumbosacral nerve root metastasis.
Jong Wook HONG ; Joung Sub YOUN ; Seung Min KIM ; San Hee LEE ; Eun Ji NAM ; Sang Woon KIM ; Jae Hoon KIM ; Young Tae KIM ; Sung Hoon KIM
Korean Journal of Obstetrics and Gynecology 2007;50(11):1547-1551
Neoplastic plexopathy is usually associated with advanced systemic cancer, regional progression of the primary tumor and complication of cancer treatment including radiotherapy. Lumbosacral plexopathy is most commonly found in colorectal cancer and its symptom begins with leg pain, and thereafter numbness and weakness develops. Radiotherapy is generally considered as the 1st line therapy for metastatic plexopathy and it is also a way to relieve pain. We experienced one case of recurrent cervix cancer with lumbosacral nerve root metastasis after radical abdominal hysterectomy without additional radiation therapy and then we report it together with a brief review of literatures.
Cervix Uteri*
;
Colorectal Neoplasms
;
Female
;
Hypesthesia
;
Hysterectomy
;
Leg
;
Neoplasm Metastasis*
;
Radiotherapy
;
Uterine Cervical Neoplasms*
6.Treatment Planning Correction Using MRI in the Radiotherapy of Cervical Cancer.
Se One SHIN ; Kil Ho CHO ; Chan Won PARK
Yeungnam University Journal of Medicine 1995;12(2):203-209
PURPOSE: To evaluate the role of MRI in the management of cervical cancer treated by conventional four-field whole pelvic irradiation. METHOD AND MATERIAL: Between 1993-march and 1994-february, 20 patients(4 Stage I B, 3 Stage U A, 13 Stage U B) with invasive cervical cancer were eligible for evaluation of accuracy of conventionally designed lateral treatment field without MRI determination. RESULTS: 5 out of 20 Patients had inadequate margin without MRI. The position of uterine fundus was more important than cervix in correction of field size and the center of treatment field. CONCLUSION: This Preliminary date show MRI determination of uterine position prior to radiotherapy planning is essential in the case of four-field whole pelvic irradiation technique.
Cervix Uteri
;
Female
;
Humans
;
Magnetic Resonance Imaging*
;
Radiotherapy*
;
Uterine Cervical Neoplasms*
7.Clinical Evaluation of Dose Distribution in High Dose Rate Intracavitary Irradiation in the Treatment of Cervical Cancer.
Yeungnam University Journal of Medicine 1989;6(1):87-98
Clinical estimation of bladder and rectal doses from high dose rate intracavitary irradiation in carcinoma of the cervix uteri has been initiated on a routine basis in an effort to obtain the optimum radiotherapeutic dose. Simulation films with contrast media are used to image the bladder and rectum, and dose rates are estimated at various interesting points with the aid of treatment planning computer, NEC Therac-2300. Fifty-three patients have been reviewed in order to ascertain the correlation between radiation dose at interesting points in the bladder and rectum and the dose at Point A and B. The dose ratio between doses at Point A and interesting points in an important clinical factor in evaluating the treatment planning. This also serves as documentation of the dose to normal structures within the treatment volume. Authors conclude that obtained data are within acceptable ranges and routine simulation films of the bladder and rectum after administration of contrast media with dose calculations at interesting points provide important information for optimizing radiotherapy planning in the treatment of cervical carcinoma without increased time and effort or patient's discomfort.
Cervix Uteri
;
Contrast Media
;
Female
;
Humans
;
Radiotherapy
;
Rectum
;
Urinary Bladder
;
Uterine Cervical Neoplasms*
8.A Case of Rectal Adenocarcinoma with Radiation Colitis.
Auk KIM ; Jin Seo LEE ; Young Deok BAE ; Ji Yong CHOI ; Kyung Ho KIM ; Chi Jun PARK ; Jin Heon LEE ; Eun Sook NAM ; Yong Bum KIM ; Hak Yang KIM ; Jae Young YOO
Korean Journal of Gastrointestinal Endoscopy 2000;21(5):873-876
Radiotherapy induced colorectal adenocarcinoma with radiation colitis after radiotherapy has been reported as a rare case. A patient with rectal adenocarcinoma as a late complication of pelvic irradiation for gynecological malignancy is reported. A 55-year-old woman with bloody diarrhea for 6 months was admitted. She received radiation therapy for carcinoma of cervix 21 years ago. Colonoscopic findings revealed a polypoid mass on rectosigmoid colon. Histopathologic examination of the polypectomy specimen disclosed adenocarcinoma. We reported herein a case of rectal adenocarcinoma with radiation colitis. The patient who had received pelvic irradiation should have close follow-up with colonoscopic study for the early detection of colorectal cancer.
Adenocarcinoma*
;
Cervix Uteri
;
Colitis*
;
Colon
;
Colorectal Neoplasms
;
Diarrhea
;
Female
;
Follow-Up Studies
;
Humans
;
Middle Aged
;
Radiotherapy
9.Early Bowel Complications Following Radiotherapy of Uterine Cervix Carcinoma.
The Journal of the Korean Society for Therapeutic Radiology and Oncology 1999;17(2):129-135
PURPOSE: This study evaluated early bowel complications in cervix cancer patients, following external radiotherapy (ERT) and high dose rate intracavitary radiation (HDR ICR). Factors affecting the risk of developing early bowel complications and its incidence are analyzed and discussed. MATERIALS AND METHODS: The study is the retrospective review of 66 patients who received radiotherapy at Chungbuk National University Hospital from April 1994 to December 1998. The patients underwent 41.4 or 50.4 Gy ERT according to FIGO stage and tumor size, then A point dose was boosted to 71.4 or 74.4 Gy using a remotely controlled afterloading Buchler HDR ICR. The EORTC/RTOG morbidity criteria were used to grade early bowel complications, which are valid from day 1, the commencement of therapy, through day 90. The actuarial incidence, severity of complications were investigated and clinical pretreatment factors relevant to complications were found through univariate (Wilcoxon) and multivariate (Cox proportional hazard model) analysis. RESULTS: Of the 66 patients, 30 patients (46%) developed early bowel complications; 25 patients (38%) with grade 1 or 2, 4 patients (6%) with grade 3 and 1 patient (2%) with grade 4. The complications usually began to occur 3 weeks after the commencement of radiotherapy. The actuarial incidence of early bowel complications was 41% at 10 weeks. The early bowel complications were associated significantly with an old age and a history of previous abdomino-pelvic surgery. All three patients who had a protracted overall treatment time (about 2 weeks) due to severe bowel complication, suffered from pelvic recurrences. CONCLUSION: Forty six percent of patients experienced early bowel complications, most of which were grade 1 or 2 and relieved spontaneously or by medication. The patients with an old age or a previous surgery have a high probability of early complications and they may be less compliant with planned radiotherapy. So more careful precaution is necessary for these patients.
Cervix Uteri*
;
Chungcheongbuk-do
;
Female
;
Humans
;
Incidence
;
Radiotherapy*
;
Recurrence
;
Retrospective Studies
;
Uterine Cervical Neoplasms
10.Spontaneous Intraperitoneal Rupture of the Urinary Bladder after Radiotherapy for Cervical Cancer.
Sun Ouck KIM ; Eu Chang HWANG ; Deok Hyun NAM ; Kwang Sung PARK ; Dong Deuk KWON ; Soo Bang RYU
Journal of the Korean Continence Society 2009;13(2):163-165
Spontaneous intraperitoneal bladder rupture is a rare complication of radiation therapy. We report an unusual case of spontaneous intraperitoneal bladder rupture 17 years after pelvic radiotherapy for carcinoma of the cervix in a 59-year-old woman who underwent prompt surgical repair.
Cervix Uteri
;
Female
;
Humans
;
Middle Aged
;
Radiotherapy*
;
Rupture*
;
Urinary Bladder*
;
Uterine Cervical Neoplasms*